Innovative Treatment for Gonorrhea: Phase III Trial Shows Promise for Zoliflodacin

Phase III trial of zoliflodacin shows it as effective as current treatments for uncomplicated gonorrhea, highlighting its potential in combating rising antibiotic resistance.

Related Keywords

Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Matt Ronsheim ,Alison Luckey ,European Society Of Clinical Microbiology ,World Health Organization ,Adobe Stock ,European Society ,Clinical Microbiology ,Infectious Diseases ,Infection Control Today ,Innoviva Specialty ,Specialty Therapeutics ,Innoviva Specialty Therapeutics ,